These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 1350456)

  • 21. c-erbB-2 oncoprotein in screen-detected breast carcinoma: an immunohistological study.
    Soomro S; Taylor P; Shepard HM; Feldmann M; Sinnett HD; Shousha S
    Int J Cancer; 1993 Aug; 55(1):63-5. PubMed ID: 8102130
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunohistochemical study of neu protein overexpression in clinging in situ duct carcinoma of the breast.
    De Potter CR; Foschini MP; Schelfhout AM; Schroeter CA; Eusebi V
    Virchows Arch A Pathol Anat Histopathol; 1993; 422(5):375-80. PubMed ID: 8100656
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunohistochemical detection of oestrogen receptors in ductal carcinoma in situ of the breast.
    Karayiannakis AJ; Bastounis EA; Chatzigianni EB; Makri GG; Alexiou D; Karamanakos P
    Eur J Surg Oncol; 1996 Dec; 22(6):578-82. PubMed ID: 9005143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neu-protein overexpression in breast cancer. Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer.
    van de Vijver MJ; Peterse JL; Mooi WJ; Wisman P; Lomans J; Dalesio O; Nusse R
    N Engl J Med; 1988 Nov; 319(19):1239-45. PubMed ID: 2903446
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunohistochemical c-erbB-2 protooncogene expression and nuclear DNA content in human mammary carcinoma in situ.
    Schimmelpenning H; Eriksson ET; Pallis L; Skoog L; Cedermark B; Auer GU
    Am J Clin Pathol; 1992 May; 97(5 Suppl 1):S48-52. PubMed ID: 1374218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between c-erbB-2 immunoreactivity and thymidine labelling index in breast carcinoma in situ.
    Barnes DM; Meyer JS; Gonzalez JG; Gullick WJ; Millis RR
    Breast Cancer Res Treat; 1991 Mar; 18(1):11-7. PubMed ID: 1677296
    [TBL] [Abstract][Full Text] [Related]  

  • 27. c-erbB-2 expression in different histological types of invasive breast carcinoma.
    Soomro S; Shousha S; Taylor P; Shepard HM; Feldmann M
    J Clin Pathol; 1991 Mar; 44(3):211-4. PubMed ID: 1672872
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p53 and c-erbB-2 protein expression in breast carcinomas. An immunohistochemical study including correlations with receptor status, proliferation markers, and clinical stage in human breast cancer.
    Barbareschi M; Leonardi E; Mauri FA; Serio G; Dalla Palma P
    Am J Clin Pathol; 1992 Oct; 98(4):408-18. PubMed ID: 1357956
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumour markers in breast carcinoma correlate with grade rather than with invasiveness.
    Wärnberg F; Nordgren H; Bergkvist L; Holmberg L
    Br J Cancer; 2001 Sep; 85(6):869-74. PubMed ID: 11556839
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple developmental pathways of highly aggressive breast cancers disclosed by comparison of histological grades and c-erbB-2 expression patterns in both the non-invasive and invasive portions.
    Tsuda H; Hirohashi S
    Pathol Int; 1998 Jul; 48(7):518-25. PubMed ID: 9701014
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunohistochemical localisation of pS2 protein in ductal carcinoma in situ and benign lesions of the breast.
    Luqmani YA; Campbell T; Soomro S; Shousha S; Rio MC; Coombes RC
    Br J Cancer; 1993 Apr; 67(4):749-53. PubMed ID: 8385977
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p53 protein expression in mammary ductal carcinoma in situ: relationship to immunohistochemical expression of estrogen receptor and c-erbB-2 protein.
    Poller DN; Roberts EC; Bell JA; Elston CW; Blamey RW; Ellis IO
    Hum Pathol; 1993 May; 24(5):463-8. PubMed ID: 8098318
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mammographically-detected ductal in situ carcinoma of the breast analyzed with a new classification. A study of 127 cases: correlation with estrogen and progesterone receptors, p53 and c-erbB-2 proteins, and proliferative activity.
    Zafrani B; Leroyer A; Fourquet A; Laurent M; Trophilme D; Validire P; Sastre-Garau X
    Semin Diagn Pathol; 1994 Aug; 11(3):208-14. PubMed ID: 7831532
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transforming growth factor beta 1 in ductal carcinoma in situ and invasive carcinomas of the breast.
    Walker RA; Dearing SJ
    Eur J Cancer; 1992; 28(2-3):641-4. PubMed ID: 1317202
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Breast carcinoma in sclerosing adenosis: a clinicopathological and immunophenotypical analysis on 206 lesions.
    Yu BH; Tang SX; Xu XL; Cheng YF; Bi R; Shui RH; Tu XY; Lu HF; Zhou XY; Yang WT
    J Clin Pathol; 2018 Jun; 71(6):546-553. PubMed ID: 29436376
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistochemical distribution of c-erbB-2 in in situ breast carcinoma--a detailed morphological analysis.
    Ramachandra S; Machin L; Ashley S; Monaghan P; Gusterson BA
    J Pathol; 1990 May; 161(1):7-14. PubMed ID: 1973459
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of HER2/neu overexpression/amplification in the progression of ductal carcinoma in situ to invasive carcinoma of the breast.
    Latta EK; Tjan S; Parkes RK; O'Malley FP
    Mod Pathol; 2002 Dec; 15(12):1318-25. PubMed ID: 12481013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biologic markers in ductal carcinoma in situ and concurrent infiltrating carcinoma. A comparison of eight contemporary grading systems.
    Leong AS; Sormunen RT; Vinyuvat S; Hamdani RW; Suthipintawong C
    Am J Clin Pathol; 2001 May; 115(5):709-18. PubMed ID: 11345835
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In situ distribution of oncogene products and growth factor receptors in breast carcinoma: c-erbB-2 oncoprotein, EGFr, and PDGFr-beta-subunit.
    Kommoss F; Colley M; Hart CE; Franklin WA
    Mol Cell Probes; 1990 Feb; 4(1):11-23. PubMed ID: 1969111
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Breast carcinoma in women 35 years and younger: a pathological study.
    Fernandopulle SM; Cher-Siangang P; Tan PH
    Pathology; 2006 Jun; 38(3):219-22. PubMed ID: 16753742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.